Britannia Announces Non-Brokered Private Placement of Unsecured Debenture Units
Britannia Announces Non-Brokered Private Placement of Unsecured Debenture Units
Britannia may engage one or more agents or finders in connection with the Offering and may pay such parties fees as may be agreed between Britannia and such parties. Britannia anticipates that current insiders of the Company may participate in the Offering.- Britannia will undertake a non-brokered private placement of units consisting of subordinated dentures and common shares for aggregate gross proceeds of up to CAD$1,000,000
- Britannia將進行一項非經紀承銷的單位定向增發，包括優先債券和普通股票，募集最高1,000,000加元的總毛收益。
Toronto, Ontario and London, United Kingdom--(Newsfile Corp. - June 7, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company"), today announced that it is undertaking a private placement of unsecured debenture units.
加拿大多倫多和英國倫敦--（Newsfile Corp. - 2024年6月7日）- 生命科學公司Britannia Life Sciences Inc.（CSE:BLAB）（FSE:L020）("Britannia") 今天宣佈，正在進行無擔保公司債券單位的非經紀定向增發。Britannia"或"公司今天宣佈，正在進行無擔保公司債券單位的非經紀定向增發。
This non-brokered private placement of subordinated debenture units (the "Units") at a price CAD$1,000 per Unit for aggregate gross proceeds of up to CAD$1,000,000 (the "Offering"). Each Unit will consist of (i) a CAD$1,000 principal amount unsecured, subordinated debenture (the "Debenture"), and (ii) 16,666 common share purchase warrants of Britannia (each, a "Common Share Purchase Warrant") at a purchase price of $0.06. The Debentures will pay interest at a rate of 10% per annum, paid annually in arrears, and will have a maturity date of 12 months from the date of issue, subject to extension at the Company's option for an additional 12 months (the "Maturity Date").
這次非經紀承銷的子公司債券單位定向增發（"增發"）每單位售價1,000加元，最高募集1,000,000加元的總毛收益。單位每個單位包括：（i）1,000加元本金的無擔保優先債券（"優先債券"），以及（ii）16,666個Britannia的普通股票購買權（每個，"普通股票購買權"），購買價格爲0.06美元。債券每年以10%的年利率支付利息，每年遞延付款，並於發行之日起12個月到期，如公司選擇可延長12個月（"到期日"）。增發計劃Britannia打算將增發的淨收益用於營運資金和一般的公司用途。公司債券在增發過程中，Britannia可能會聘請一個或多個代理或尋找者，並向該方支付雙方同意的費用。Britannia預計，公司現任內部人員可能會參與增發。增發預計將於2024年6月21日或其他日期關閉，視公司確定而定，並受到某些條件的約束，包括但不限於獲得所有必要的批准，包括加拿大證券交易所（CSE）的批准。增發可以在收到認購後的一個或多個檔次關閉。關於Britannia Life Sciences Inc.到期日").
Britannia intends to use the net proceeds of the Offering for working capital and general corporate purposes.
Britannia Life Sciences Inc.專注於將尖端技術引入傳統實驗室和監管平台，爲客戶提供數據驅動的見解，以改善其客戶的結果。Britannia爲消費品行業提供服務，包括一套綜合服務，以幫助公司沿着其產品開發之旅前進。Britannia的服務包括產品配方、安全評估、分析和微生物檢測、全球合規、消費者評估，爲跨國公司和初創公司提供服務，特別是在化妝品、食品和健康產業中。Britannia還通過其子公司Britannia Mining Solutions爲自然資源行業提供地球化學測試和分析。Britannia Mining Solutions在美國運營地球化學實驗室，並正在全球範圍內推出12臺PhotonAssay機器，目前已安裝並投入運行兩臺PhotonAssay機器。Britannia的總部位於加拿大多倫多阿德萊德大街西120號2400號套房，M5H 1T1。
Britannia may engage one or more agents or finders in connection with the Offering and may pay such parties fees as may be agreed between Britannia and such parties. Britannia anticipates that current insiders of the Company may participate in the Offering.
如果對Britannia在多個行業中不斷增長的產品開發、分析測試、監管和合規解決方案有任何疑問或了解更多信息，請訪問或聯繫：
The Offering is expected to close on or about June 21, 2024, or such other date as the Company may determine, and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the Canadian Securities Exchange (CSE). The Offering may be closed in one or more tranches as subscriptions are received.
Peter Shippen，首席執行官，電話：+1 416 930 7711或+44 738 744 7441，電子郵件：peter@britannia.life
About Britannia Life Sciences Inc.
請參閱Britannia Life Sciences Inc.：
Britannia Life Sciences Inc. is focused on introducing cutting-edge technologies into the traditional laboratory and regulatory platforms to power data-driven insights to improve the outcomes of its customers. Britannia provides services to the consumer products sector included an integrated suite of services to assist companies along their product development journey. Britannia's services, including product formulations, safety assessments, analytical and microbiological testing, global compliance, and consumer evaluations are offered to companies ranging from multinationals to startups particularly in the cosmetics, food, and wellness industries. Britannia also provides geochemical testing and analysis to the natural resources industry through its subsidiary Britannia Mining Solutions. Britannia Mining Solutions operates a geochemical laboratory in the United States and is in the process of rolling out 12 PhotonAssay machines globally, with two PhotonAssayTM units installed and commissioned to-date.. Britannia's head office is located at 120 Adelaide Street West, Suite 2400, Toronto, Ontario, M5H 1T1.
Britannia Life Sciences Inc.專注於將尖端技術引入傳統實驗室和監管平台，爲客戶提供數據驅動的見解，以改善其客戶的結果。此款超便攜式投影儀使用了最新的 Android TV 界面，而且遙控器還內置了 Google AssistantTM 功能，用戶可以非常方便地使用它。Britannia爲消費品行業提供服務，包括一套綜合服務，以幫助公司沿着其產品開發之旅前進。Britannia的服務包括產品配方、安全評估、分析和微生物檢測、全球合規、消費者評估，爲跨國公司和初創公司提供服務，特別是在化妝品、食品和健康產業中。Britannia還通過其子公司Britannia Mining Solutions爲自然資源行業提供地球化學測試和分析。Britannia Mining Solutions在美國運營地球化學實驗室，並正在全球範圍內推出12臺PhotonAssay機器，目前已安裝並投入運行兩臺PhotonAssay機器。Britannia的總部位於加拿大多倫多阿德萊德大街西120號2400號套房，M5H 1T1。
For inquiries or more information on Britannia's growing suite of product development, analytical testing, regulatory and compliance solutions across a range of industries, please visit or contact:
如需了解有關Britannia在各行業中日益增長的產品開發、分析測試、監管和合規解決方案的查詢或更多信息，請訪問
Peter Shippen, CEO
Tel: +1 416 930 7711 or +44 738 744 7441
Email: peter@britannia.life
Peter Shippen, 首席執行官電話：+1 416 930 7711或+44 738 744 7441，電子郵件：peter@britannia.life
電話：+1 416 930 7711 或 +44 738 744 7441
電子郵件: peter@britannia.life
譯文內容由第三人軟體翻譯。